•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.Empower Clinics Provides Corporate Update
Empower Clinics Announces Closing of Second Tranche Private Placement Financing
Empower Clinics Announces Closing of First Tranche Private Placement Financing
Empower Clinics Announces Proposal For Division Spin Out
Empower Clinics Signs New Agreements To Advance Growth Of Research and Clinical Trials with Signing Of Two Additional Principal Investigators - And Are Approved To Process Multiple Clinical Study Applications From Pharmaceutical Sponsors
Empower Clinics signs letter of intent for equity capital facility
Empower Clinics looks to expand research opportunities, utilize financial advisor to grow shareholder value
Empower Clinics signs fourth principal investigator for Dallas site
Empower Clinics adds two new researchers to support clinical trials services at its site in Dallas
Empower Clinics signs clinical trials services deal with Texas medical group
Empower Clinics commences process to explore and evaluate strategic options
Empower Clinics advances partnership to launch US clinical trial management services
Empower Clinics ends Q4 2022 with $193,144 in cash; continues to focus on clinical trial services
Empower Clinics partners with nuclear medicine specialist to launch US clinical trial management services
Empower Clinics announces partnership with Fobi AI unit to elevate investor relations with digital, mobile and personalized engagement
Empower Clinics says subsidiary MediSure's diabetes test strips get OK for government programs
Empower Clinics announces an offering of units at a price of 3 cents each for aggregate gross proceeds of between $2M and $5M
Empower Clinics consolidates three medical clinics to focus on flagship Etobicoke integrated medical clinic
Empower Clinics says MediSure Laboratory signs laboratory services agreement with Alp MedTech AG
Empower Clinics taps Zeifmans LLP as new auditor as it boosts accounting and financial controls